Access to health care in Africa - changing the paradigm for access and quality
16 April 2008
- 18 April 2008
ARV Access for Africa (AA4A)
Venue: Cape Town, South Africa
Contact person: /
ARV Access for Africa (AA4A), a subsidiary of IDA Solutions in the Netherlands is proud to announce a symposium/ aimed at examining and solving some of the current challenges to the reliable supply, quality of care and effective use of HIV/AIDS and related medicines and diagnostics, and capacity development. The main challenges include quality assurance of medicines, the supply chain itself, including selection, procurement, pricing, licensing, medicines for children, the actual care which patients receive and the lack of human and other resource capacity.
Objectives
The symposium will explore these challenges at a high level, contribute to the debate about them, challenge conventional wisdom about how best to deal with them and explore new directions in solving them. It will function as a forum for the dissemination of information about these challenges. It will provide a unique opportunity to take forward and achieve progress in their resolution.
Four themes:
Day 1: (Theme 1) - The efficiency and integrity of the supply chain itself, including prices and procurement.
Day 2: (Theme 2) - The quality of medicines and other supplies. (Theme 3) - The quality of patient care.
Day 3: (Theme 4) - Sustainability and capacity building.
A key international speaker will introduce a theme, followed by a high level interactive panel and participant discussion. The discussion will be focused on specific questions which will be circulated in advance and others which arise in situ. For each session, the main points from the debate will be summarized and any recommendations formulated.
Target audience
In addition to the participation of major role-players as discussed above, the target audience for the symposium is at country level, including directors and managers who report to national, provincial and state government political structures, as well as other high level representatives of organisations involved in these activities.
|
